Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva, in the UK for the treatment of chronic obstructive ...
Watford, England, April 13, 2022: Glenmark Pharmaceuticals has been awarded the Pharmacy Business Innovation in Generics Award for its capsule-based inhaler Tiogiva (tiotropium). The company developed ...
Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name - Tiogiva, in UK for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results